Dewey McLin
Directeur Technique/Scientifique/R&D chez LONGBOARD PHARMACEUTICALS, INC.
Profil
Dewey McLin is currently the Vice President & Head-Medical Affairs at Longboard Pharmaceuticals, Inc. Previously, he held the position of Senior Director-Medical Affairs at Greenwich Biosciences, Inc. In 2021, he briefly served as the Vice President-Medical Affairs at Sesen Bio, Inc. Dr. McLin completed his undergraduate degree at Indiana University and obtained a doctorate from the University of California, Irvine.
Postes actifs de Dewey McLin
| Sociétés | Poste | Début |
|---|---|---|
| LONGBOARD PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Dewey McLin
| Sociétés | Poste | Fin |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/09/2021 |
Greenwich Biosciences, Inc.
 Greenwich Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Greenwich Biosciences, Inc. develops and markets cannabinoid prescription medicines through online. The company is headquartered in Carlsbad, CA. | Directeur Technique/Scientifique/R&D | - |
Formation de Dewey McLin
| Indiana University | Undergraduate Degree |
| University of California, Irvine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LONGBOARD PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Greenwich Biosciences, Inc.
Greenwich Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Greenwich Biosciences, Inc. develops and markets cannabinoid prescription medicines through online. The company is headquartered in Carlsbad, CA. | Health Technology |
